Clinical Trial Update: Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and toxicity of SBRT followed by intratumoral PCX12 immunotherapy for locally advanced pancreatic adenocarcinoma; trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• PCX12

Snippet

Sponsor: Haoming (Carl) Qiu | Conditions: Pancreatic Adenocarcinoma | Phase 1 | Status: NOT_YET_RECRUITING